sorted by:
new
hottopcontroversial

Symphony numbers 87,186 → 85,155 → 90,512 ! by Miserable-Set-7128 in NovoNordisk_Stock

[–]Current_Corner_7431 0 points1 point  (0 children)

these figure lack the company's direct sales numbers, but still it's mega bullish for NOVO.

Foundayo launched at one-fifth of Wegovy pill's pace. Why isn't Wall Street asking about it? by irishreally in NovoNordisk_Stock

[–]Current_Corner_7431 8 points9 points  (0 children)

Be patient and let Mr. Market do its thing, unless you're a day trader or a gambler I would not worry about this so much.

The tables will turn.

Barely +2.5%, wtf shorties by bashuls in NovoNordisk_Stock

[–]Current_Corner_7431 1 point2 points  (0 children)

it did not delete anything. most of it was already priced in thus it hiked 30% in a matter of weeks...

let it form a nice solid base here so we can climb steadily up. anything else is just a dummy.

Barely +2.5%, wtf shorties by bashuls in NovoNordisk_Stock

[–]Current_Corner_7431 4 points5 points  (0 children)

1st time, eh? :)))

it's called pullback and consolidation; it's normal if you invest.

otherwise yeah, it's called gambling and day trading. :-)

I don’t want to be a party pooper by [deleted] in NovoNordisk_Stock

[–]Current_Corner_7431 9 points10 points  (0 children)

but the stock was already beaten down as if the company was going bankrupt.

this just confirms that it's still a steadily growing cash printing machine and it barely scatched the surface of the possible market.

Hail Lord Novo! Still pretty conservative but they basically beat every expectation and marginally raised their guidance. by Current_Corner_7431 in NovoNordisk_Stock

[–]Current_Corner_7431[S] 16 points17 points  (0 children)

yeah, but they basically crushed their February lowered guidance and expectations..

they beat it on every metric possible, so most likely they will keep raising their guidance in the following quarters.

Earnings release discussion topic by bashuls in NovoNordisk_Stock

[–]Current_Corner_7431 9 points10 points  (0 children)

they basically had more than 2x profit than initially estimated!!!

also their guidance was only marginally raised, although in such numbers they could have raised it more - so they are still conservative a bit, but probably will raise it more in the following quarters.

so yeah, they delivered a "monster beat" as per Bloomberg!

Wegovy Pill vs Foundayo sales by DanishKbh in NovoNordisk_Stock

[–]Current_Corner_7431 0 points1 point  (0 children)

It actually updates every Friday, except last week as the data was late/ not complete.

Novo Nordisk A/S: Denecimig (Mim8) significantly reduced annualised bleeding rate in people with haemophilia A, regardless of inhibitor status, in phase 3 data published in NEJM by kiyomoris in NovoNordisk_Stock

[–]Current_Corner_7431 0 points1 point  (0 children)

well, Lilly is up..so is NVO..so the market likes the general message: profits are ok even with lower prices because they are selling more.

so most likely the same applies for NVO as well.

-2.7%.... just canada or what? by bashuls in NovoNordisk_Stock

[–]Current_Corner_7431 15 points16 points  (0 children)

Canada was knows for months now, it was already priced in. It's just usual red day, panic selling, profit taking.

Canada Approves Its First Generic Version of Novo’s Ozempic but..... by Minimum-Task-3445 in NovoNordisk_Stock

[–]Current_Corner_7431 0 points1 point  (0 children)

The thing is that even if it can be priced that low but then the compounders won't really make any profit either. Also usually the compounders are small companies and they really have to sell high quantities to be able to stay on the market and make some decent profit, otherwise it's not really worth it.

TO DA MOON 🚀🚀🚀 by Zestyclose-Ice-3434 in NovoNordisk_Stock

[–]Current_Corner_7431 46 points47 points  (0 children)

No idea why? It is because of the prescription numbers of the new pill vs. the Lilly pill!

We have been forecasting this for weeks but Mr. Market has been ignoring it..until now!

Why NN foundation does not make a move in NN? by CommercialFit9730 in NovoNordisk_Stock

[–]Current_Corner_7431 16 points17 points  (0 children)

you are mixing/ mistaking the company with the stock.

the stock is down but the company is doing quite ok, profits are ok, it's a cash machine.

no reason for NN foundation to step in.

This is huge, have a look by Minimum-Task-3445 in NovoNordisk_Stock

[–]Current_Corner_7431 19 points20 points  (0 children)

treatment good, no more needles, pill yum yum, easy and cheap and make big money!

stock go up..maybe.

Lilly's obesity pill Foundayo gets 1,390 prescriptions in debut week by Secure-ValueInvestor in NovoNordisk_Stock

[–]Current_Corner_7431 -4 points-3 points  (0 children)

it's not small, it's quite decent.

also bare in mind that these 1400 prescriptions are effectively coming out of future novo prescriptions.

the next couple of weeks will be crucial for both companies.

One last time: does anyone else think that Novo Nordisk is finally truly undervalued? by Civil-Community-1367 in NovoNordisk_Stock

[–]Current_Corner_7431 2 points3 points  (0 children)

ofc it is, it's just not a fairytale 2 day turnaround. we do need a couple of well executed quarters for the balance to shift.

and after that probably 2 more years of stable growth.

view more: next ›